Exondys 51
Active substance: eteplirsen
INJECTION · ETEPLIRSEN 50 mg/mL
United StatesActive
Marketing holder: Sarepta Therapeutics, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ETEPLIRSEN · 50 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-5891-729b-90fd-87aa11428487,01a1208f-8219-7939-94d9-2819b76167e3,01a12092-09b9-72a2-8bae-69484981eef4,01a12095-6afc-7cfb-9550-dfc3cc855bf6;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 60923-363
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 60923-363 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 60923-363 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 60923-363 · Verified 2026-10-09 · open in source